Skip to main content
. 2014 May-Jun;76(3):179–187.

Fig. 4.

Fig. 4

Chromatogram of marketed formulation of OLM, AML and HCTZ.

Chromatogram of marketed formulation of olmesartan (OLM, Rf= 0.77), amlodipine (AML, Rf = 0.21) and hydrochlorthiazide (HCTZ, Rf = 0.47)